Nestlé Shares Soar 8% on Surprise Q3 Sales, 16,000-Job Cut Plan – What’s Next?

Nestlé Shocks Investors: 8% Stock Rally After Blowout Q3 and 16,000 Jobs on the Line

Key Facts: Nestlé’s stock jumped about 8% on Oct. 16 – its steepest one-day gain since 2008 [1] [2]. That followed a surprise 4.3% rise in Q3 organic sales (versus ~3.7% expected) [3], with its volume metric (real internal growth) at +1.5% (far above the +0.3% forecast) [4]. New CEO Philipp Navratil announced a costly “turnaround” plan: 16,000 job cuts (roughly 6% of the global workforce) over two years [5] [6] and an increased cost-savings goal of CHF 3.0 billion by 2027 [7] [8]. Navratil said “the world is changing, and Nestlé needs to change faster,” warning that “hard but necessary” job cuts are coming [9]. Analysts cheered the news – Vontobel’s Jean-Philippe Bertschy said the results “should partly restore investors’ trust,” while Bernstein called the earnings “fuel to the turnaround fire” [10] [11]. Many analysts have raised their Nestlé price targets (the average 12-month target is now ~CHF 87, and RBC Capital maintains ~CHF 93) [12]. Nestlé reaffirmed its 2025 guidance (organic growth improving, margin ≥16%) [13], but warned that a strong Swiss franc and new U.S. tariffs could “dampen” profits [14].

Surprising Q3 Sales Rebound

Nestlé reported a better-than-expected quarter on all fronts. Organic (currency-adjusted) sales grew ~4.3% in Q3, above analyst forecasts of ~3.7% [15]. The growth was led by higher prices and strong demand in key categories like coffee and confectionery [16] [17]. Importantly, Nestlé’s real internal growth (RIG) – a key volume measure – rebounded to +1.5%, well above the +0.3% expected [18]. Volumes in North America and Europe firmed up, although Greater China remained a drag (Nestlé says it will refocus on building demand there) [19] [20]. The solid results reflect Nestlé’s effort to invest behind brands and innovation: as CEO Navratil noted, the company is “stepping up investment… and the results are starting to come through” [21] [22]. CFO Anna Manz admitted Nestlé had “over-invested in distribution” in China and is correcting course to drive local demand [23]. On the earnings call, Nestlé reiterated that it still expects 2025 organic growth to improve versus 2024 and an operating margin at or above ~16% [24] [25].

Bold Job-Cut Plan and Strategy Shift

Just weeks into his tenure (he was appointed in early September), CEO Philipp Navratil unveiled one of the most aggressive cost-cutting plans in Nestlé’s history. The company will slash 16,000 jobs globally by 2027 – about 6% of its ~277,000 workforce [26] [27]. Roughly 12,000 of those cuts will be white-collar roles, with the remaining 4,000 in manufacturing and supply-chain functions [28]. This accelerates Navratil’s predecessor’s efficiency program: Nestlé is raising its total cost-saving goal to CHF 3.0 billion by end-2027 (up from CHF 2.5 billion) [29] [30].

Navratil framed the cuts as part of a turnaround push. “The world is changing and Nestlé needs to change faster,” he said, noting that the moves were “hard but necessary decisions” [31]. He vowed to build a lean, performance-driven culture: “We are fostering a culture that embraces a performance mindset that does not accept losing market share,” he said, adding that the company will be “ruthless in assessing our people” to see who delivers results [32] [33]. Analysts at RBC Capital Markets applauded this tone – James Edwardes-Jones said he “welcomed Navratil’s ambition to foster a culture…where losing market share is not accepted” [34]. Nestlé also signaled it will review underperforming businesses (for example, exploring strategic options for its bottled water and vitamin divisions) as part of this push [35] [36].

Stock Market Rally and Outlook

News of the sales beat and job cuts sent Nestlé’s shares sharply higher. The stock surged as much as 8.2% in Swiss trading on Oct. 16 – its largest one-day jump since 2008 [37] [38]. By the end of Thursday, the Swiss-market (SMI) stock was near CHF 82.10, up from around CHF 75 the previous close [39] [40]. This rally lifted Switzerland’s market index and underscored investor relief that Nestlé might finally arrest a years-long slide in growth.

Looking ahead, analysts are now more optimistic on Nestlé’s stock. TipRanks shows the average 12-month Nestlé target at ~CHF 87.13 (roughly 20% above recent prices), and even before the rally, RBC Capital was modeling a CHF 93 target [41]. Those price targets assume mid-single-digit organic growth (around 3–4%) and stable margins (around 16–17%) in 2025 [42]. Nestlé’s management reaffirmed that 2025 guidance after the quarter, saying it still expects organic growth to pick up and underlying margin to be ~16% or higher [43]. The company also highlighted its strong free cash flow conversion (nearly 90%) and a dividend yield around 2.7%, making it attractive to defensive investors.

However, Nestlé cautioned that headwinds remain. The Swiss franc has been unusually strong, and new U.S. tariffs on Swiss goods (now at 39% on some imports) will bite into profit in 2026–27 [44] [45]. Rising input costs (in commodities like milk and palm oil) are another threat: Nestlé warned that inflationary pressures could “dampen” profits [46]. In its sector, global consumer staples stocks have largely lagged growth sectors this year, so some analysts see Nestlé’s rebound as a positive sign of defensive stocks catching up [47].

Analyst and Expert Take

Experts gave the quarter high marks, but stressed that delivery is key. “These results should partly restore investors’ trust,” said Vontobel analyst Jean-Philippe Bertschy [48]. Bernstein Research called the surprise job cuts and sales beat “fuel to the turnaround fire,” noting the aggressive action is exactly what investors have been asking for [49]. RBC’s Edwardes-Jones said Navratil’s assertive stance was welcome, and importantly, the rebound in volumes (the +1.5% RIG) suggests the market is responding to Nestlé’s investments. The Guardian quoted Navratil promising to invest boldly: “We will be bolder in investing at scale and driving innovation… we are fostering a culture… where winning is rewarded” [50].

Still, some analysts urge caution. Nestlé’s Q4 commentary will be closely watched to see if momentum continues. Even with raised targets, Wall Street consensus still generally rates Nestlé as a “hold” (indicating mixed views on upside) [51]. Market-watchers will compare Nestlé’s performance to peers (like Unilever or Coca-Cola) in the staples sector. For now, the message is that Nestlé has its board’s commitment to a leaner structure and is starting to see green shoots in growth – and its stock rally suggests investors are cautiously betting on a sustainable turnaround [52] [53].

Sources: Nestlé Q3 earnings release and comments, Swissinfo/Reuters/Bloomberg news reports [54] [55]; analyst research (Vontobel, RBC, Bernstein) as reported by Reuters/Swissinfo [56] [57]; TS2.tech market analysis [58]; financial media (The Guardian) [59]; and LSEG/FT equity data [60].

Nestle to Cut 16,000 jobs as new CEO targets sales growth

References

1. www.swissinfo.ch, 2. ts2.tech, 3. www.reuters.com, 4. www.reuters.com, 5. www.swissinfo.ch, 6. www.theguardian.com, 7. www.swissinfo.ch, 8. www.theguardian.com, 9. www.swissinfo.ch, 10. ts2.tech, 11. www.reuters.com, 12. ts2.tech, 13. ts2.tech, 14. ts2.tech, 15. www.reuters.com, 16. www.reuters.com, 17. ts2.tech, 18. www.reuters.com, 19. www.reuters.com, 20. ts2.tech, 21. www.theguardian.com, 22. www.swissinfo.ch, 23. www.reuters.com, 24. ts2.tech, 25. www.reuters.com, 26. www.swissinfo.ch, 27. www.theguardian.com, 28. www.theguardian.com, 29. www.swissinfo.ch, 30. www.theguardian.com, 31. www.swissinfo.ch, 32. www.reuters.com, 33. www.swissinfo.ch, 34. ts2.tech, 35. ts2.tech, 36. www.swissinfo.ch, 37. www.swissinfo.ch, 38. ts2.tech, 39. markets.ft.com, 40. www.swissinfo.ch, 41. ts2.tech, 42. ts2.tech, 43. ts2.tech, 44. ts2.tech, 45. www.reuters.com, 46. ts2.tech, 47. ts2.tech, 48. ts2.tech, 49. www.reuters.com, 50. www.theguardian.com, 51. www.marketbeat.com, 52. ts2.tech, 53. www.swissinfo.ch, 54. www.swissinfo.ch, 55. www.reuters.com, 56. ts2.tech, 57. www.reuters.com, 58. ts2.tech, 59. www.theguardian.com, 60. markets.ft.com

Stock Market Today

  • Snap Stock Surges 18% on $400 Million Perplexity AI Deal
    November 6, 2025, 7:33 AM EST. Snap (SNAP) jumped 18% in pre-market after beating Q3 revenue estimates and announcing a $500 million stock buyback. Revenue rose to $1.51 billion, above expectations of $1.49B, while daily active users reached 477 million. The company inked a $400 million partnership with AI search startup Perplexity to embed its conversational search into Snapchat, starting in early 2026. The move diversifies revenue beyond ads, though the company warns about potential Q4 headwinds from Apple/Google age-verification changes and Australia's restrictions. Profitability improved, with net losses narrowing over 30% YoY and adjusted EBITDA of $182 million. Analysts' price targets and upside discussions remain mixed amid a year-to-date decline.
  • Is Elevance Health a Hidden Opportunity After a 24.5% Drop in 2025?
    November 6, 2025, 7:28 AM EST. Elevance Health has tumbled in 2025 amid policy shifts and broader healthcare-sector volatility, with a year-to-date drawdown and a longer 24.5% slide that has investors rethinking value. The piece weighs near- and long-term catalysts, noting that a high valuation score isn't translating into certainty as government program changes loom for managed care. The core takeaway is a rigorous DCF assessment, which, using current free cash flow of $3.6B and projected growth, yields an intrinsic value around $1,090.84 per share-roughly 71% above current prices, signaling undervaluation. Still, equity investors should monitor the PE ratio, competitive dynamics, and policy risk, which could affect how quickly this perceived bargain translates into realized gains.
  • Inflammation Biotech Evommune Starts NYSE Trading in $150M IPO
    November 6, 2025, 7:24 AM EST. Evommune is heading to the NYSE with a $150 million IPO to fund two clinical-stage assets. The Palo Alto biopharma is offering 9.3 million shares at $16 each, pricing in the $15-$17 range. Gross proceeds are $150 million, potentially rising by about $22.5 million if underwriters exercise their option for an additional 1.4 million shares. Trading under the ticker EVMN could begin today. The company plans to use the funds to advance two phase 2 programs, including EVO756, an oral MRGPRX2 antagonist being studied for CSU and atopic dermatitis (AD). Topline data for CSU from a phase 2 study showed 93% responses at four weeks. Data for AD topline in H2 2026. Evommune priced amid a broader biotech IPO backdrop as MapLight Therapeutics went public last week.
  • Arm Holdings Stock Surges on Q2 Beat, Strong AI Demand Lifts Outlook
    November 6, 2025, 7:22 AM EST. Arm Holdings (ARM) stock jumps about 5-6% in pre-market trading after reporting a Q2 beat that topped revenue and earnings estimates and issuing stronger Q3 guidance. The company posted revenue of $1.14 billion, up 34% year over year, and EPS of $0.22, exceeds consensus of $0.13. Arm also raised its quarterly revenue guide to about $1.23 billion versus the $1.10 billion expected. Royalty revenue reached a record $620 million, up 21%, led by data centers, automotive, and IoT, with hyperscalers like Google, Amazon, and Microsoft boosting Arm-based deployments. Licensing revenue rose 56% to $515 million. The AI infrastructure buildout underscores demand for Arm's energy-efficient designs, and management hints at potential in-house chip development beyond licensing.
  • Capital One Stock Prediction: Analysts See Up to 29% Upside by 2027 on Discover Acquisition
    November 6, 2025, 7:20 AM EST. Capital One (NYSE: COF) trades around $221 with an average target near $260, implying ~18% upside. Targets span $290 (high) and $210 (low), with a median near $258 and a mix of 14 Buys, 3 Outperforms, and 6 Holds. Growth projections call for revenue up about 19% annually through 2027, supported by operating margins near 48% and a forward multiple around 9.7x. A guided model points to ~$285/share by 2027, or about 29% total upside (12% annualized). The story centers on the Discover acquisition, expanded payments network, and stable credit trends amid solid consumer spending, though conviction remains modest and upside depends on continued earnings growth and credit stability.
Bitdeer Stock Skyrockets 30% on Bitcoin Boom and AI Pivot – Analysts See More Upside
Previous Story

Bitdeer Stock Skyrockets 30% on Bitcoin Boom and AI Pivot – Analysts See More Upside

Sonder Holdings (SOND) Stock Skyrockets 50% After Q2 Earnings and New Partnership Surprise
Next Story

Sonder Holdings (SOND) Stock Skyrockets 50% After Q2 Earnings and New Partnership Surprise

Go toTop